DalsnaFinance › IPOs › Arcutis Biotherapeutics Inc › IPO
Arcutis Biotherapeutics, Inc. completed its initial public offering on NASDAQ on January 31, 2020, pricing at $17.00 a share.
| Ticker | ARQT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 31, 2020 |
| Offering price | $17.00 |
| Shares offered | 9,375,000 |
| Total raised | $159M |
Arcutis Biotherapeutics, Inc. sold 9,375,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $159.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $159 million total recorded for the deal.
Arcutis Biotherapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Arcutis Biotherapeutics, Inc.. This page is general information, not investment advice.